Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP880721.RAkYna_FvR_aZ-7jl_79RFdT5H2w_16kUwOjmMMmvIFNU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP880721.RAkYna_FvR_aZ-7jl_79RFdT5H2w_16kUwOjmMMmvIFNU130_assertion type Assertion NP880721.RAkYna_FvR_aZ-7jl_79RFdT5H2w_16kUwOjmMMmvIFNU130_head.
- NP880721.RAkYna_FvR_aZ-7jl_79RFdT5H2w_16kUwOjmMMmvIFNU130_assertion description "[Furthermore, higher GluR2 immunoreactivity was associated with milder cognitive impairment and lower concentrations of A?42 peptide and phosphorylated tau.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880721.RAkYna_FvR_aZ-7jl_79RFdT5H2w_16kUwOjmMMmvIFNU130_provenance.
- NP880721.RAkYna_FvR_aZ-7jl_79RFdT5H2w_16kUwOjmMMmvIFNU130_assertion evidence source_evidence_literature NP880721.RAkYna_FvR_aZ-7jl_79RFdT5H2w_16kUwOjmMMmvIFNU130_provenance.
- NP880721.RAkYna_FvR_aZ-7jl_79RFdT5H2w_16kUwOjmMMmvIFNU130_assertion SIO_000772 21419184 NP880721.RAkYna_FvR_aZ-7jl_79RFdT5H2w_16kUwOjmMMmvIFNU130_provenance.
- NP880721.RAkYna_FvR_aZ-7jl_79RFdT5H2w_16kUwOjmMMmvIFNU130_assertion wasDerivedFrom befree-2016 NP880721.RAkYna_FvR_aZ-7jl_79RFdT5H2w_16kUwOjmMMmvIFNU130_provenance.
- NP880721.RAkYna_FvR_aZ-7jl_79RFdT5H2w_16kUwOjmMMmvIFNU130_assertion wasGeneratedBy ECO_0000203 NP880721.RAkYna_FvR_aZ-7jl_79RFdT5H2w_16kUwOjmMMmvIFNU130_provenance.